Recent summary of changes to the LAM
The tables below show a summary of changes to the list of approved medicines (LAM) since it was last published. The LAM is published monthly or more frequently if required.
Additions
| Epoetin lambda (Novicrit®) injection 1000 units/0.5 mL, 2000 units/1 mL, 3000 units/0.3 mL, 4000 units/0.4 mL, 5000 units/0.5 mL, 6000 units/0.6 mL, 8000 units/0.8 mL, 10 000 units/1 mL, syringe - (pending depletion of Eprex stock) |
Amendments
| Cyclizine injection 50 mg/mL |
| Dexamfetamine tablet 5 mg |
| Droperidol injection 2.5 mg/mL |
| Lisdexamfetamine capsule 20mg, 30mg, 40mg, 50mg, 60mg, 70mg |
| Methylphenidate modified release capsule 10 mg, 20 mg, 30 mg, 40 mg, 60 mg (e.g. Ritalin LA®) |
| Methylphenidate modified release tablet 18 mg, 27 mg, 36 mg, 54 mg (e.g. Concerta®) |
| Methylphenidate tablet 10mg |
| Obinutuzumab injection 1 g/40 mL |
| Olanzapine orally disintegrating tablet 10 mg |
| Olanzapine orally disintegrating tablet 5 mg |
| Olanzapine tablet 10 mg |
| Olanzapine tablet 2.5 mg |
| Olanzapine tablet 5 mg |
| Olanzapine tablet 7.5 mg |
| Olanzapine wafer 5 mg, 10 mg |
Deletions
